SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,363,322 | -73.6% | 66,245 | -39.8% | 0.00% | -100.0% |
| Q2 2023 | $5,172,388 | +109.3% | 110,004 | +86.8% | 0.00% | 0.0% |
| Q1 2023 | $2,471,444 | -25.8% | 58,900 | -32.5% | 0.00% | 0.0% |
| Q4 2022 | $3,329,622 | -0.3% | 87,300 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $3,341,000 | +18.6% | 85,308 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $2,818,000 | -20.1% | 87,253 | -18.1% | 0.00% | 0.0% |
| Q1 2022 | $3,528,000 | +42.5% | 106,593 | +83.2% | 0.00% | 0.0% |
| Q4 2021 | $2,475,000 | -55.8% | 58,185 | -54.0% | 0.00% | 0.0% |
| Q3 2021 | $5,604,000 | -82.3% | 126,477 | -77.3% | 0.00% | -87.5% |
| Q2 2021 | $31,598,000 | -71.6% | 556,204 | -62.6% | 0.01% | -73.3% |
| Q1 2021 | $111,363,000 | -13.3% | 1,487,817 | +0.2% | 0.03% | -18.9% |
| Q4 2020 | $128,433,000 | +40.6% | 1,484,593 | -0.7% | 0.04% | +19.4% |
| Q3 2020 | $91,367,000 | +26.4% | 1,494,886 | -14.0% | 0.03% | +19.2% |
| Q2 2020 | $72,282,000 | +42.8% | 1,738,408 | -1.4% | 0.03% | +23.8% |
| Q1 2020 | $50,622,000 | -65.3% | 1,762,611 | -12.7% | 0.02% | -53.3% |
| Q4 2019 | $145,792,000 | -43.3% | 2,019,556 | +10.3% | 0.04% | -32.8% |
| Q3 2019 | $256,983,000 | -30.6% | 1,831,793 | -9.4% | 0.07% | -29.5% |
| Q2 2019 | $370,201,000 | +242.2% | 2,021,964 | +197.2% | 0.10% | +163.9% |
| Q1 2019 | $108,193,000 | +77.8% | 680,244 | +7.1% | 0.04% | +56.5% |
| Q4 2018 | $60,841,000 | -25.4% | 635,149 | +10.0% | 0.02% | -11.5% |
| Q3 2018 | $81,571,000 | +53.1% | 577,494 | +69.7% | 0.03% | +44.4% |
| Q2 2018 | $53,277,000 | +127.9% | 340,361 | +134.5% | 0.02% | +100.0% |
| Q1 2018 | $23,382,000 | +196.0% | 145,170 | +202.7% | 0.01% | +200.0% |
| Q4 2017 | $7,900,000 | +16.3% | 47,959 | -56.0% | 0.00% | 0.0% |
| Q3 2017 | $6,790,000 | -22.4% | 108,993 | -0.8% | 0.00% | 0.0% |
| Q2 2017 | $8,746,000 | -13.3% | 109,821 | -22.6% | 0.00% | 0.0% |
| Q1 2017 | $10,087,000 | +31.4% | 141,937 | -5.6% | 0.00% | 0.0% |
| Q4 2016 | $7,675,000 | +66.3% | 150,309 | +50.0% | 0.00% | +50.0% |
| Q3 2016 | $4,616,000 | +262.9% | 100,231 | +152.6% | 0.00% | +100.0% |
| Q1 2016 | $1,272,000 | +25340.0% | 39,687 | +53531.1% | 0.00% | – |
| Q2 2015 | $5,000 | – | 74 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |